Decontamination is incomplete or not adequately demonstrated to ensure prevention of cross-contamination.
Inspection Record
Genlbet Biopbarmaceuticals SA — FDA 483 Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
Equipment cleaning processes are inadequate.
Written procedures for decontamination, cleaning, and maintenance of equipment are deficient regarding sufficient details to protect equipment from contamination prior to use.
A record as of the US FDA document published on 2026-10-20. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.